Login to Your Account



Merck-dumped Paratek Woos Novartis: $485M Antibiotic Deal

By Catherine Hollingsworth


Friday, October 9, 2009
Privately held Paratek Pharmaceuticals Inc. has found another partner to help develop its antibiotic PTK 0796 for life-threatening infections, this time joining with Swiss drugmaker Novartis AG in a deal valued at up to $485 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription